Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Serena Lunardi, Nigel B. Jamieson, Su Yin Lim, Kristin L. Griffiths, Manuela Carvalho-Gaspar, Osama Al-Assar, Sabira Yameen, Ross C. Carter, Colin J. McKay, Gabriele Spoletini, Stefano D’Ugo, Michael A. Silva, Owen J. Sansom, Klaus-Peter Janssen, Ruth J. Muschel, Thomas B. Brunner
Published Nov 11, 2014 · Vol. 5, No. 22 · pp. 11064-11080
Kerstin A. David, Florian T. Unger, Philipp Uhlig, Hartmut Juhl, Helen M. Moore, Carolyn Compton, Björn Nashan, Arnulf Dörner, Andreas de Weerth, Carsten Zornig
Published Nov 3, 2014 · Vol. 5, No. 22 · pp. 11017-11028
Carmine Carbone, Geny Piro, Matteo Fassan, Anna Tamburrino, Maria Mihaela Mina, Marco Zanotto, Paul J. Chiao, Claudio Bassi, Aldo Scarpa, Giampaolo Tortora, Davide Melisi
Published Oct 24, 2014 · Vol. 6, No. 15 · pp. 13822-13834